Godavari Drugs Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 405.47 million compared to INR 386.67 million a year ago. Revenue was INR 406.79 million compared to INR 387.57 million a year ago. Net income was INR 8.64 million compared to INR 12.21 million a year ago. Basic earnings per share from continuing operations was INR 1.15 compared to INR 1.62 a year ago. Diluted earnings per share from continuing operations was INR 1.15 compared to INR 1.62 a year ago.
For the six months, sales was INR 830.97 million compared to INR 830.69 million a year ago. Revenue was INR 832.96 million compared to INR 831.76 million a year ago. Net income was INR 17.85 million compared to INR 26.46 million a year ago. Basic earnings per share from continuing operations was INR 2.37 compared to INR 3.51 a year ago. Diluted earnings per share from continuing operations was INR 2.37 compared to INR 3.51 a year ago.